Can M&A Activity Drive Quest Diagnostics (DGX) Q4 Earnings?
Zacks Investment Research | Feb 10, 2019 09:19PM ET
Quest Diagnostics Incorporated (NYSE:DGX) is scheduled to report fourth-quarter 2018 earnings before the opening bell on Feb 14.
In the last reported quarter, the company’s earnings were in line with the Zacks Consensus Estimate. However, average trailing four-quarter beat was delivered at 0.18%.
Let’s take a look at how things are shaping up prior to this announcement.
Factors at Play
On a positive note, Quest Diagnostics seems well-aligned with its agenda to accelerate growth and drive operational excellence. Per its new long-term progress outlook, revenue increase for the period 2017-2020 is expected to be 3-5% with 1-2% rise projected from acquisitions. Earnings for the period are anticipated to surge faster than the top line in the mid-to-high single- digit range.
Per the company, its frequently growing partnerships with other health care leaders and strategic acquisitions are creating promising opportunities for the top and the bottom line while improving the patient experience and reducing the overall cost of care.
In third-quarter 2018, the company satisfied all five elements of the above-mentioned growth agenda and strongly expects this momentum to continue, going forward.
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.